Allspring Global Investments’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-51
Closed -$516 2897
2023
Q2
$516 Sell
51
-153
-75% -$1.62K ﹤0.01% 2672
2023
Q1
$2.08K Buy
+204
New +$2.33K ﹤0.01% 2708
2022
Q3
Sell
-1,574
Closed -$20K 2951
2022
Q2
$20K Hold
1,574
﹤0.01% 2489
2022
Q1
$26K Buy
+1,574
New +$26.7K ﹤0.01% 2921

Other funds holding TSVT

Allspring Global Investments's TSVT Position: Q3 2023 in Review

Allspring Global Investments sold out of 2seventy bio (TSVT) in Q3 2023, closing a stake of 51 shares — an estimated $516 sold.

Allspring Global Investments first reported a position in TSVT in Q1 2022 and held it in 4 quarters. The position peaked at $26K in Q1 2022. 145 funds tracked by Wall St. Rank hold TSVT as of Q3 2023.

  • Allspring Global Investments reported no remaining 2seventy bio position as of Q3 2023 after selling out during the quarter.
  • Allspring Global Investments sold 51 2seventy bio shares in Q3 2023, an estimated $516.
  • Allspring Global Investments first reported a position in 2seventy bio in Q1 2022 and held it in 4 quarters.
  • Allspring Global Investments's 2seventy bio position peaked at $26K in Q1 2022.
  • 145 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2023.

Based on Allspring Global Investments's 13F filing for Q3 2023, filed 27 Oct 2023.